OLANDER CLINICAL CONSULTING 1 ApS: Financial statements 2023
CVR: 35532900
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
OLANDER CLINICAL CONSULTING 1 ApS (CVR 35532900) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -7,581 and a net result of DKK 23,757 compared with DKK 29,664 the year before. Equity in the 2023 report amounted to DKK 107,703. The solvency ratio was 91.3%.
- Revenue
- DKK 0
- Gross Profit
- DKK -7,581
- Profit/Loss
- DKK 23,757
- Equity
- DKK 107,703
- Total Assets
- DKK 118,011
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -8K | 24K | 108K | - |
| 2022 | - | -7K | 30K | 114K | - |
| 2021 | - | -7K | 29K | 109K | - |
| 2020 | - | -6K | 23K | 104K | - |
| 2019 | - | -6K | 22K | 108K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
OLANDER CLINICAL CONSULTING 1 ApS has published its annual report for 2022. Gross profit came to DKK -7,257, and the net result was DKK 29,664.
About OLANDER CLINICAL CONSULTING 1 ApS
OLANDER CLINICAL CONSULTING 1 ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. The company has 0 employees (2015). In 2025, the company reported a gross profit of DKK 38,365 and a net result of DKK 28,455 compared with DKK 30,979 the year before. Equity in the 2025 report amounted to DKK 167,137.
